KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Receivables (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Change in Receivables data on record, last reported at $111.7 million in Q4 2025.

  • For Q4 2025, Change in Receivables rose 125.2% year-over-year to $111.7 million; the TTM value through Dec 2025 reached $127.3 million, up 41.92%, while the annual FY2025 figure was $127.3 million, 41.92% up from the prior year.
  • Change in Receivables reached $111.7 million in Q4 2025 per ZBH's latest filing, up from -$3.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $111.7 million in Q4 2025 and bottomed at -$34.8 million in Q1 2021.
  • Average Change in Receivables over 5 years is $24.7 million, with a median of $20.8 million recorded in 2024.
  • Peak YoY movement for Change in Receivables: surged 1157.69% in 2022, then plummeted 2183.33% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $38.8 million in 2021, then soared by 80.93% to $70.2 million in 2022, then fell by 3.99% to $67.4 million in 2023, then fell by 26.41% to $49.6 million in 2024, then skyrocketed by 125.2% to $111.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $111.7 million in Q4 2025, -$3.0 million in Q3 2025, and -$200000.0 in Q2 2025.